M. Chrysochoidis: We are facing a revolution in the field of health Liberal.gr

The Minister of Health spoke about new data in the field of health, recruitment, modern form in the EOPPY organization, pharmaceutical policy, Michalis Chrysochoidis, during his presentation at a conference organized by the Economist in Athens. It is important that many of the new technologies are now finding applications in health “and if we add to that Artificial Intelligenceone realizes that we are in for a revolution in health”.

According to ERT, the Minister of Health emphasized that there are still many unresolved questions problems which should be addressed and have a procedure of urgency. As he explained, “the biggest problem in Europe today is the lack of a workforce in the health sector, because “it is estimated that over 1 million workers are missing in the health sector, be it doctors, nurses or administrative staff. , a fact which, combined with increasing life expectancy, is putting great pressure on all systems”.

He said 5,500 to 6,000 were made recruitment in 2023 and many have been launched for 2024. Speaking about the rationalization of the system’s expenses, he pointedly emphasized: “Competition and competition everywhere. Transparency and data at all costs”.

As he added, all this in combination with the digital transformation in the healthcare sector, the establishment of the oncology patient registry, the digital patient file and the complete digitization of hospital records will improve control and reduce waste.

Mr. Chrysochoidis talked about one modern form in the EOPPY organization which “will function as a modern insurance company and will be fully digitized”.

With reference to the issue pharmaceutical policy, said the goal is “not to hold back any innovation from patients, but to have the drugs they really need after they’ve been evaluated.” He also mentioned that the priority is the management of innovative medicines, which make up a large part of the expenditure. In connection with the pharmaceutical policy, there is already a reduction in the recovery of funds, and the funding from the recovery fund contributes to this. Fifty million for last year, 150 million for this year, and three hundred million for 2024.”

“The aim is to move to a national pharmaceutical policy with all the necessary medicines for citizens, with evaluation and cost control, and all this will be subject to the EOF and there will be important negotiations by the EOPPY.”

The purpose is to “further develop the Greek pharmaceutical industry, because it is lucky for Greece that it exists,” said the health minister, referring to the emergence of chronic diseases, which increase with increasing life expectancy. centers that will monitor all patients holistically, referring to the example of a patient with diabetes. “This patient should also be monitored for vision problems. Problems with the heart, but also on a psychological level,” he concluded.

At the round table that followed, the president of the Panhellenic Federation of the Pharmaceutical Industry (PEF), Theodoros Tryfon, emphasized that it was now clear that “a new page is being opened internationally in terms of the adequacy and safety of basic needs in Europe, as well as medicine”. He said it was key to “bring some of the production back from Asia to Europe”, but admitted that regulations and red tape, as well as additional costs – such as environmental costs – made the task difficult. The question, he said, is “how patients will continue to have access to more effective, better quality and cheaper drugs.”

He believes that a new pharmaceutical policy is needed to produce more medicines in Europe. Referring to Greece, he said that there are currently 45 pharmaceutical factories, i.e. one in ten in the European Union, adding that the Greek pharmaceutical industry is creating new investments with the help of the government. But as he explained, “excessive taxation of pharmaceutical companies needs to be addressed because we require predictability, which is much more important to us than increasing our turnover”.

In turn, EOPPY director Theano Karpodini pointed out that digital transformation and artificial intelligence “will help EOPPY to use the amount of data at its disposal and to modernize its services”.

This, he said, will have an impact on addressing polypharmacy, prescription control and protecting the patient and the system from excessive drug costs. Referring to the rebate and clawback, she said “it was a necessary mechanism for fiscal adjustment in a period of crisis”. He explained that the purpose was to be a temporary measure to rationalize spending, while also emphasizing that in 2014 the return was 240 million euros and today it has reached 1.5 billion euros. “EOPPY is making great efforts with the new pharmaceutical policy to reduce excesses and rationalize costs,” he emphasized, pointing out that “the negotiating commission has already achieved a significant reduction in EOPPY’s spending and also in terms of hospital drugs.”

Orestis Kavalakis, commander of the Special Coordination Service of the Recovery Fund, emphasized that “by 2026, the funds from the Recovery Fund will change the country’s health for the better”, pointing out that 42 health projects worth 2.17 billion euros – the largest amount that has been devoted to public health in the post-covid era – in recent years.

This money, he said, will go towards infrastructure and equipment in 97 public hospitals and 156 health centers, which are strengthened and overall contribute to the improvement of primary health care. They will also get them on prevention programs, mental health reform, and digital transformation, which includes, among other things, an electronic patient record. He stressed that raising the funds “is a very big challenge because it requires an unprecedented coordination effort between many agencies.” Absorption takes place only with implementation, because, as he said, “the money is paid out only when it starts to be implemented and the phases of project implementation can be seen. Once the recovery fund ends, in August 2026, we will be talking about a different and better health system,” he concluded.

Leave a Reply

Your email address will not be published. Required fields are marked *